연구성과로 돌아가기
2024 연구자 정보 (47 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Dae-Yeon (Kim, DY) |
Univ Ulsan, Coll Med, Seoul Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea |
|
|
[JCR상위 1.7] Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) [JCR상위 9.6] Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial) |
SCIE | 1.7 |
ONCOLOGY OBSTETRICS & GYNECOLOGY;ONCOLOGY |
rohjuwon@hanmail.net; | ||
|
Kim, Eun Ae (Kim, EA) |
Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea |
|
0000-0002-7639-8962 Kim, Eun-Ae |
[JCR상위 1.7] Uncovering of NRAGE/JNK and PI3K/AKT pathways through serial WGS of patients with breast cancer [JCR상위 44.0] Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer |
SCIE | 1.7 | ONCOLOGY | yschae@knu.ac.kr; | ||
|
Kim, Hark Kyun (Kim, HK) |
Natl Canc Ctr, Ctr Gastr Canc Res Inst & Hosp, Grad Sch Canc Sci & Policy, Goyang, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Kim, Haseok (Kim, H) |
MDT-5309-2025 Kim, Haseok |
|
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC) [JCR상위 1.7] Pre-treatment CT radiomics for predicting immunotherapy response in non-small cell lung cancer(NSCLC): RECIST vs. irRECIST criteria [JCR상위 1.7] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) [JCR상위 1.7] AI-based radiomics model for predicting immune checkpoint inhibitor-related pneumonitis (CIP) in patients with advanced NSCLC: An external validation study |
SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Hee Jung (Kim, HJ) |
|
|
[JCR상위 1.7] Analysis of prognostic factors in uterine cervical malignancy treated with concurrent chemoradiation therapy: A retrospective study in two centers in Korea. | SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Hong-Kyu (Kim, HK) |
Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea |
C-6000-2008 AAA-3402-2022 Park, Hong-Gyu Kim, Seunghyun |
0000-0003-4425-972X Kim, Hong-Kyu |
[JCR상위 1.7] Long-term oncologic outcome of breast-conserving surgery in breast cancer with BRCA 1/2 mutation (ON-BRCA II, KoREa-BSG 06) [JCR상위 61.2] Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial |
SCIE | 1.7 | ONCOLOGY | likeicetea@hanmail.net;hblee.md@snu.ac.kr; | ||
|
Kim, Hye Jung (Kim, HJ) |
Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, Daegu, South Korea Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, 807 Hoguk Ro, Daegu 41404, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Radiol, 807 Hoguk Ro, Daegu, South Korea Kyungpook Natl Univ Hosp, Dept Radiol, Daegu, South Korea Gyeongsang Natl Univ, Coll Med, Inst Med Sci, Dept Pharmacol, Jinju 52727, South Korea Gyeongsang Natl Univ, Coll Med, Dept Convergence Med Sci, Jinju, South Korea Kyungpook Natl Univ, Chilgok Hosp, Dept Radiol, Daegu, South Korea Gyeongsang Natl Univ, Inst Hlth Sci, Coll Med, Dept Pharmacol, Jinju 52727, South Korea Gyeongsang Natl Univ, Coll Med, Dept Convergence Med Sci, Jinju 52727, South Korea |
|
|
[JCR상위 1.7] Ten-year outcomes of targeted axillary surgery after neoadjuvant chemotherapy in breast cancer [JCR상위 36.0] Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer [JCR상위 91.3] Lupus Mastitis Manifesting as Extensive Calcification in the Retromammary Area: A Case Report [JCR상위 91.3] Primary Invasive Ductal Carcinoma Arising in Axillary Accessory Breast: A Case Report [JCR상위 10.1] Clinical Feasibility of Dual-Layer CT With Virtual Monochromatic Image for Preoperative Staging in Patients With Breast Cancer: A Comparison With Breast MRI [JCR상위 15.5] Activation of neurotoxic A1-reactive astrocytes by SFTS virus infection accelerates fatal brain damage in IFNAR1⁻/⁻ mice [JCR상위 22.3] Corrigendum: Improving the diagnostic performance of inexperienced readers for thyroid nodules through digital self-learning and artificial intelligence assistance (vol 15, 1372397,2024) [JCR상위 22.3] Improving the diagnostic performance of inexperienced readers for thyroid nodules through digital self-learning and artificial intelligence assistance [JCR상위 7.4] SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model |
SCIE ESCI |
1.7 |
ONCOLOGY RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING VIROLOGY ENDOCRINOLOGY & METABOLISM CELL BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL |
phy123@knu.ac.kr; mamrad@knu.ac.kr; mamrad@knu.ac.kr;oaktree9@knu.ac.kr; hjkim1945@gnu.ac.kr;resina78@naver.com;spyun@gnu.ac.kr; ant637@knuh.kr;docjin@yuhs.ac; lks1314@wku.ac.kr;yjkim1@khu.ac.kr;spyun@gnu.ac.kr; |
||
|
Kim, Hye Sung (Kim, HS) |
LQV-0440-2024 Kim, Hye Sung |
|
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC) [JCR상위 1.7] AI-based radiomics model for predicting immune checkpoint inhibitor-related pneumonitis (CIP) in patients with advanced NSCLC: An external validation study |
SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Hyo Song (Kim, HS) |
Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea |
D-5568-2011 Kim, Hyun |
0000-0002-0625-9828 Kim, Hyo Song |
[JCR상위 1.7] Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma [JCR상위 7.0] Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial |
SCIE | 1.7 |
ONCOLOGY MULTIDISCIPLINARY SCIENCES |
hyosong77@yuhs.ac; | ||
|
Kim, Ji Yeon (Kim, JY) |
|
|
[JCR상위 1.7] Early versus conventional adjuvant chemotherapy in stage III colon cancer: A multicenter, randomized, open-label, phase 3 trial | SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Leeseul (Kim, L) |
Ascension St Francis Hosp, Dept Internal Med, Evanston, IL USA |
|
|
[JCR상위 1.7] Pre-treatment CT radiomics for predicting immunotherapy response in non-small cell lung cancer(NSCLC): RECIST vs. irRECIST criteria [JCR상위 1.7] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) [JCR상위 37.6] Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy |
SCIE | 1.7 | ONCOLOGY | YCHAE@nm.org; | ||
|
Kim, Sanghwa (Kim, S) |
AAA-3402-2022 Kim, Seunghyun |
|
[JCR상위 1.7] Long-term oncologic outcome of breast-conserving surgery in breast cancer with BRCA 1/2 mutation (ON-BRCA II, KoREa-BSG 06) | SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Won Hwa (Kim, WH) |
Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, Daegu, South Korea Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, 807 Hoguk Ro, Daegu 41404, South Korea Kyungpook Natl Univ Hosp, Dept Radiol, Daegu, South Korea |
|
|
[JCR상위 1.7] Ten-year outcomes of targeted axillary surgery after neoadjuvant chemotherapy in breast cancer [JCR상위 36.0] Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer [JCR상위 91.3] Lupus Mastitis Manifesting as Extensive Calcification in the Retromammary Area: A Case Report [JCR상위 10.1] Clinical Feasibility of Dual-Layer CT With Virtual Monochromatic Image for Preoperative Staging in Patients With Breast Cancer: A Comparison With Breast MRI |
SCIE ESCI |
1.7 |
ONCOLOGY RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING |
phy123@knu.ac.kr; mamrad@knu.ac.kr; mamrad@knu.ac.kr;oaktree9@knu.ac.kr; |
||
|
Kim, Yuchan (Kim, Y) |
|
|
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC) [JCR상위 1.7] Pre-treatment CT radiomics for predicting immunotherapy response in non-small cell lung cancer(NSCLC): RECIST vs. irRECIST criteria [JCR상위 1.7] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) [JCR상위 1.7] AI-based radiomics model for predicting immune checkpoint inhibitor-related pneumonitis (CIP) in patients with advanced NSCLC: An external validation study |
SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Yun Hwan (Kim, YH) |
Ewha Womans Univ, Mokdong Hosp, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea |
|
0000-0001-9498-2938 Kim, Yun Hwan |
[JCR상위 1.7] Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) [JCR상위 9.6] Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial) |
SCIE | 1.7 |
ONCOLOGY OBSTETRICS & GYNECOLOGY;ONCOLOGY |
rohjuwon@hanmail.net; |
페이지 이동: